Improving the Treatment of Acute Relapses in Multiple Sclerosis Through Intranasal Methylprednisolone Administration
Clinical trial NCT06223074 · ENROLLING_BY_INVITATION
Trial details
- NCT number
- NCT06223074
- Sponsor
- Universidad Nacional Autonoma de Mexico
- Status
- ENROLLING_BY_INVITATION
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-01-09
- Primary completion
- 2026-02-25
- Enrollment
- 80
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.